|
|
Informa Life Sciences
|
|
| Toxicogenomics in Drug Safety Assessment |
|
|
|
|
|
|
| |
|
 |
|
|
|
|
| |
Mon 03 Dec 2007
- Thu 06 Dec 2007
Danubius Regents Park, London, United Kingdom
|
|
|
|
We are very pleased to announce that the 2nd Annual Toxicogenomics in Drug Safety Assessment will be opening its doors on 4th and 5th December 2007, London.
The conference will explore the growing field of Toxicogenomics and will feature the following topics:
- Toxicogenomics regulatory acceptance issues
- Toxicogenomics mechanism and predictive-based investigations
- Toxicogenomics case studies
- Application of 'omics' technology platforms
- Developing and validating toxicogenomics biomarkers
- The value of bioinformatics data in toxicogenomics
|
Don't Miss
Weida Tong, Director, Center for Toxicoinformatics, Division of Systems Toxicology, FDA
Juergen Borlak, Director, Fraunhofer Institute of Toxicology and Experimental Medicine, Centre for Drug Research and Medical Biotechnology, Chair in Pharmaco and Toxicogenomics, Center of Pharmacology and Toxicology, Medical School of Hannover
Maria L Beaumont, Investigator, General Toxicology, Safety Assessment UK, GlaxoSmithKline
Gregor Tuschl, Non-Clinical Development, Merck Serono
Philip Hewitt, Head of Toxicogenomics, Institute of Toxicology, Merck Serono
Nandini Raghaven, Department of Non-Clinical Biostatistics, Johnson & Johnson
Yi Yang, Associate Research Investigator, Cellular and Molecular Toxicology, Abbott
Thomas Thum, Junior Research Group Cardiac Wounding/Healing, Interdisciplinary Center for Clinical Research (IZKF) and Department of Cardiology, Julius-Maximilians - University of Wuerzburg
|
|
|
|
|
|
|
|
|
|
|